Australia · Company Research
CSL (ASX:CSL) Shares Have Rallied 40%. Now Trump’s Drug-Pricing Deal Adds a New Catalyst
CSL (ASX:CSL) has reached new agreements with the Trump administration covering U.S. drug pricing and domestic manufacturing, adding another important development to the healthcare giant’s recent recovery story.…
